Do you agree that in SLE/LN managament, we should target a reduction of Glucocorticoid to below 5mg/day for the shortest possible period, and with target to complete withdrawal?

• Strongly Agree
• Agree
• Neutral
• Disagree
• Strongly Disagree

Is the early introduction of biologics (e.g. Belimumab) as part of standard/initial treatment of SLE/LN respectively, help to slow down or prevent progression to organ damage in SLE and the progression to ESKD in LN, and help in steroid tapering?

• Strongly Agree
• Agree
• Neutral
• Disagree
• Strongly Disagree

How the new EULAR 2023 recommendations align with the reality of your practice?

• Not sure, not familiar enough with all the changes
• Not well aligned, as they don't often resonate with clinical cases.
• Partly aligned, there is discrepancies between recommendations and real-life clinical situations.
• Mostly aligned, generally match my clinical practice with some minor differences.
• Fully aligned, mirror my real-life clinical situations.